Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention

نویسندگان

  • Christopher J. Logothetis
  • Cory Abate-Shen
  • Powel H. Brown
  • Nancy H. Colburn
  • Eugene W. Gerner
  • Jeffery E. Green
  • Martin Lipkin
  • William G. Nelson
  • M. Scott Lucia
  • Amy K. Darke
  • Phyllis J. Goodman
  • Francisco G. La Rosa
  • Howard L. Parnes
  • Leslie G. Ford
  • Charles A. Coltman
  • Mary W. Redman
  • Catherine M. Tangen
  • Ximing Tang
  • Marileila Varella-Garcia
  • Ana Carolina Xavier
  • Erminia Massarelli
  • Natalie Ozburn
  • Jie Zhang
  • Kentaro Iwanaga
  • Kuicheon C. Choi
  • Marie Wislez
  • Maria Gabriela Raso
  • Wei Wei
  • Ignacio I. Wistuba
  • Robert A. Newman
  • Peiying Yang
  • Xi Kathy Zhou
  • Reid P. Bissonnette
  • Andrew J. Dannenberg
  • Richard G. Stevens
  • Theresa P. Pretlow
  • D. Paul Hurlstone
چکیده

Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention. M. Scott Lucia, Amy K. Darke, Phyllis J. Goodman, Francisco G. La Rosa, Howard L. Parnes, Leslie G. Ford, Charles A. Coltman, Jr. and Ian M. Thompson ................................................................................................167

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Words of wisdom. Re: Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.

The Prostate Cancer Prevention Trial (PCPT) showed a risk of prostate cancer at prostate-specific antigen (PSA) <4.0 ng/mL and that prostate cancer risk is reduced by finasteride. A major concern about early detection by PSA and prevention by finasteride is that they may involve biologically inconsequential tumors. We reviewed the pathologic characteristics of prostate biopsies from men in the ...

متن کامل

PSA Screening in Prostate Cancer

Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...

متن کامل

p53 Protein Expression and Its Relation to the Apoptotic Index in Prostate Adenocarcinoma

Background: Prostate cancer is one of the most commonly diagnosed cancers in males. Tumor suppressor gene p53 plays an important role in causing cell cycle arrest and allowing apoptosis to proceed. Objective: To investigate the expression of p53 protein and its relation to apoptosis and prostate cancer traditional prognostic indicators. Methods: In this study expression of p53 was examined in p...

متن کامل

Cancer Prevention Research Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention

The Prostate Cancer Prevention Trial (PCPT) showed a risk of prostate cancer at prostatespecific antigen (PSA) <4.0 ng/mL and that prostate cancer risk is reduced by finasteride. A major concern about early detection by PSA and prevention by finasteride is that they may involve biologically inconsequential tumors. We reviewed the pathologic characteristics of prostate biopsies from men in the p...

متن کامل

Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey

Objective(s): The aim of this study was to analyze detection rates and effectiveness of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program for prostate cancer in Japan, which is defined as a cancer-screening program for subjects without known cancer. It contains FDG-PET aimed at detection of cancer at an early stage with or without additional screening tests ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2008